177 related articles for article (PubMed ID: 10962443)
41. p53 mutations in larynx cancer.
Zhang LF; Hemminki K; Szyfter K; Szyfter W; Söderkvist P
Carcinogenesis; 1994 Dec; 15(12):2949-51. PubMed ID: 8001261
[TBL] [Abstract][Full Text] [Related]
42. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE
Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974
[TBL] [Abstract][Full Text] [Related]
43. Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung.
Hussain SP; Amstad P; Raja K; Sawyer M; Hofseth L; Shields PG; Hewer A; Phillips DH; Ryberg D; Haugen A; Harris CC
Cancer Res; 2001 Sep; 61(17):6350-5. PubMed ID: 11522624
[TBL] [Abstract][Full Text] [Related]
44. p53 and K-ras mutations in lung cancers from former and never-smoking women.
Vähäkangas KH; Bennett WP; Castrén K; Welsh JA; Khan MA; Blömeke B; Alavanja MC; Harris CC
Cancer Res; 2001 Jun; 61(11):4350-6. PubMed ID: 11389059
[TBL] [Abstract][Full Text] [Related]
45. Prevalence and spectrum of p53 mutations associated with smoking in breast cancer.
Conway K; Edmiston SN; Cui L; Drouin SS; Pang J; He M; Tse CK; Geradts J; Dressler L; Liu ET; Millikan R; Newman B
Cancer Res; 2002 Apr; 62(7):1987-95. PubMed ID: 11929815
[TBL] [Abstract][Full Text] [Related]
46. Mutations in the p53 gene in schistosomal bladder cancer: a study of 92 tumours from Egyptian patients and a comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumours.
Warren W; Biggs PJ; el-Baz M; Ghoneim MA; Stratton MR; Venitt S
Carcinogenesis; 1995 May; 16(5):1181-9. PubMed ID: 7767983
[TBL] [Abstract][Full Text] [Related]
47. TP53 mutation pattern of esophageal squamous cell carcinomas in a high risk area (Southern Brazil): role of life style factors.
Pütz A; Hartmann AA; Fontes PR; Alexandre CO; Silveira DA; Klug SJ; Rabes HM
Int J Cancer; 2002 Mar; 98(1):99-105. PubMed ID: 11857392
[TBL] [Abstract][Full Text] [Related]
48. Carcinomas of the renal pelvis associated with smoking and phenacetin abuse: p53 mutations and polymorphism of carcinogen-metabolising enzymes.
Bringuier PP; McCredie M; Sauter G; Bilous M; Stewart J; Mihatsch MJ; Kleihues P; Ohgaki H
Int J Cancer; 1998 Oct; 79(5):531-6. PubMed ID: 9761125
[TBL] [Abstract][Full Text] [Related]
49. p53 Mutations in carcinoma of the esophagus and gastroesophageal junction.
Sengpiel C; König IR; Rades D; Noack F; Duchrow M; Schild SE; Ludwig D; Homann N
Cancer Invest; 2009 Jan; 27(1):96-104. PubMed ID: 19160092
[TBL] [Abstract][Full Text] [Related]
50. Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations.
Hollstein MC; Peri L; Mandard AM; Welsh JA; Montesano R; Metcalf RA; Bak M; Harris CC
Cancer Res; 1991 Aug; 51(15):4102-6. PubMed ID: 1855226
[TBL] [Abstract][Full Text] [Related]
51. Oral squamous cell carcinoma from users and nonusers of tobacco and alcohol: clinicopathologic features and immunoreactivity of VEGF, caspase-3, and p53.
Scheidt JH; Yurgel LS; Romanini J; Cherubini K; de Figueiredo MA; Salum FG
Appl Immunohistochem Mol Morphol; 2013 Mar; 21(2):148-53. PubMed ID: 22595944
[TBL] [Abstract][Full Text] [Related]
52. Patterns of p53 G-->T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke.
Hainaut P; Pfeifer GP
Carcinogenesis; 2001 Mar; 22(3):367-74. PubMed ID: 11238174
[TBL] [Abstract][Full Text] [Related]
53. Prevalence of microsatellite instability, inactivation of mismatch repair genes, p53 mutation, and human papillomavirus infection in Korean oral cancer patients.
Shin KH; Park KH; Hong HJ; Kim JM; Oh JE; Choung PH; Min BM
Int J Oncol; 2002 Aug; 21(2):297-302. PubMed ID: 12118324
[TBL] [Abstract][Full Text] [Related]
54. p53 alterations and HPV infections are common in oral SCC: p53 gene mutations correlate with the absence of HPV 16-E6 DNA.
Penhallow J; Steingrimsdottir H; Elamin F; Warnakulasuriya S; Farzaneh F; Johnson N; Tavassoli M
Int J Oncol; 1998 Jan; 12(1):59-68. PubMed ID: 9454887
[TBL] [Abstract][Full Text] [Related]
55. p53, but not p16 mutations in oral squamous cell carcinomas are associated with specific CYP1A1 and GSTM1 polymorphic genotypes and patient tobacco use.
Lazarus P; Sheikh SN; Ren Q; Schantz SP; Stern JC; Richie JP; Park JY
Carcinogenesis; 1998 Mar; 19(3):509-14. PubMed ID: 9525287
[TBL] [Abstract][Full Text] [Related]
56. Human papilloma viruses and p53 mutations in normal pre-malignant and malignant oral epithelia.
Mao EJ; Schwartz SM; Daling JR; Oda D; Tickman L; Beckmann AM
Int J Cancer; 1996 Apr; 69(2):152-8. PubMed ID: 8608985
[TBL] [Abstract][Full Text] [Related]
57. Prevalence of p53 mutations and protein expression in esophageal cancers in southern Thailand.
Suwiwat S; Oda H; Shimizu Y; Ishikawa T
Int J Cancer; 1997 Jul; 72(1):23-6. PubMed ID: 9212217
[TBL] [Abstract][Full Text] [Related]
58. P53 and MDM2 co-expression in tobacco and betel chewing-associated oral squamous cell carcinomas.
Shwe M; Chiguchi G; Yamada S; Nakajima T; Maung KK; Takagi M; Amagasa T; Tsuchida N
J Med Dent Sci; 2001 Dec; 48(4):113-9. PubMed ID: 12160248
[TBL] [Abstract][Full Text] [Related]
59. The p53 tumor-suppressor gene and ras oncogene mutations in oral squamous-cell carcinoma.
Sakai E; Rikimaru K; Ueda M; Matsumoto Y; Ishii N; Enomoto S; Yamamoto H; Tsuchida N
Int J Cancer; 1992 Dec; 52(6):867-72. PubMed ID: 1459726
[TBL] [Abstract][Full Text] [Related]
60. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers.
Pfeifer GP; Denissenko MF; Olivier M; Tretyakova N; Hecht SS; Hainaut P
Oncogene; 2002 Oct; 21(48):7435-51. PubMed ID: 12379884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]